CLINICAL_TRIALS
trial_result
· 2020-07-21
Clinical Trial Update: A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only [Phase 2]
Summary
Phase 2 trial comparing R-CHOP plus Enzastaurin versus R-CHOP alone in lymphoma; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2020-07-21